Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New meningitis b vaccine trial for korean infants shows promise

NCT ID NCT06113198

First seen Apr 08, 2026 · Last updated May 22, 2026 · Updated 9 times

Summary

This study looks at how well a meningitis B vaccine works and how safe it is for healthy babies starting at 2 months old in South Korea. About 50 infants will receive two initial doses and one booster shot. Researchers will measure the immune response and watch for any side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MENINGITIS, MENINGOCOCCAL are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • GSK Investigational Site

    Incheon, 6510, South Korea

  • GSK Investigational Site

    Junggu, 400711, South Korea

  • GSK Investigational Site

    Kyungki-do, 14068, South Korea

  • GSK Investigational Site

    Seongnam-si Gyeonggi-do, 13620, South Korea

  • GSK Investigational Site

    Seoul, 02841, South Korea

  • GSK Investigational Site

    Seoul, 05505, South Korea

  • GSK Investigational Site

    Seoul, 07804, South Korea

  • GSK Investigational Site

    Seoul, 137701, South Korea

Conditions

Explore the condition pages connected to this study.